Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
59 North Communications is a specialized healthcare communications agency that provides strategic medical affairs and scientific communication services to the pharmaceutical and biotechnology industries. The company focuses on bridging the gap between complex clinical data and actionable medical insights through services such as medical writing, publication planning, and strategic consultancy. By leveraging deep scientific expertise, 59 North Communications helps life science companies effectively communicate the value and safety of their therapies to healthcare professionals and stakeholders. Their work typically supports products across various stages of the lifecycle, from late-stage development through to commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 59 North Communications.